Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$971M |
| 3 |
Tesla
TSLA
|
+$937M |
| 4 |
NVIDIA
NVDA
|
+$773M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$742M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$291M |
| 2 |
Willis Towers Watson
WTW
|
+$256M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$227M |
| 4 |
Salesforce
CRM
|
+$225M |
| 5 |
Advanced Micro Devices
AMD
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.9% |
| 2 | Financials | 6.62% |
| 3 | Healthcare | 6.1% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Industrials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Danaos Corp
DAC
$2.58B
| $3.96M | ﹤0.01% |
53,119
-10,928
| -17% | -$789K |
|
3077
ARS Pharmaceuticals
SPRY
$509M
| $3.96M | ﹤0.01% |
595,259
-358,432
| -38% | -$2.91M |
|
|
MRSN
3078
DELISTED
Mersana Therapeutics
MRSN
| $3.96M | ﹤0.01% |
25,443
+21,294
| +513% | +$4.14M |
|
3079
Metallus
MTUS
$838M
| $3.95M | ﹤0.01% |
239,649
+179,928
| +301% | +$2.62M |
|
|
IGAC
3080
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
| $3.94M | ﹤0.01% |
402,056
-11,413
| -3% | -$112K |
|
3081
CALL
Deere & Co
DE
$160B
| $3.94M | ﹤0.01% |
11,500
-61,500
| -84% | -$21.4M |
|
|
ANAC
3082
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
| $3.94M | ﹤0.01% |
403,547
-3,876
| -1% | -$37.9K |
|
3083
TFI International
TFII
$11.1B
| $3.94M | ﹤0.01% |
35,164
-763,922
| -96% | -$83.1M |
|
3084
TIM SA
TIMB
$9.16B
| $3.94M | ﹤0.01% |
338,633
+50,652
| +18% | +$574K |
|
3085
Duolingo
DUOL
$6.28B
| $3.94M | ﹤0.01% |
+37,097
| New | +$5.11M |
|
|
EXAS
3086
CALL
DELISTED
Exact Sciences
EXAS
| $3.93M | ﹤0.01% |
+50,500
| New | +$4.46M |
|
|
TRIT
3087
CALL
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
| $3.93M | ﹤0.01% |
11,910,500
+455,000
| +4% | +$2.26M |
|
3088
CALL
Carnival Corporation Ltd
CCL
$38.1B
| $3.92M | ﹤0.01% |
195,100
+20,500
| +12% | +$438K |
|
3089
BioAtla
BCAB
$5.46M
| $3.92M | ﹤0.01% |
3,996
+2,745
| +219% | +$3.51M |
|
3090
Walker & Dunlop
WD
$1.71B
| $3.92M | ﹤0.01% |
25,965
-78,099
| -75% | -$10.9M |
|
3091
AtaiBeckley Inc
ATAI
$2.66B
| $3.92M | ﹤0.01% |
513,272
+28,847
| +6% | +$350K |
|
3092
CALL
American Airlines Group
AAL
$10.1B
| $3.91M | ﹤0.01% |
217,900
-300,000
| -58% | -$5.75M |
|
3093
CALL
ResMed
RMD
$30.6B
| $3.91M | ﹤0.01% |
15,000
-14,200
| -49% | -$3.68M |
|
|
SVFB
3094
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
| $3.91M | ﹤0.01% |
394,656
+92,688
| +31% | +$919K |
|
3095
SLM Corp
SLM
$4.89B
| $3.9M | ﹤0.01% |
198,497
-360,781
| -65% | -$6.61M |
|
|
ECOL
3096
DELISTED
US Ecology, Inc.
ECOL
| $3.9M | ﹤0.01% |
122,179
+99,002
| +427% | +$3.27M |
|
|
BNR
3097
Burning Rock Biotech
BNR
$93.9M
| $3.9M | ﹤0.01% |
40,932
+31,130
| +318% | +$4.26M |
|
3098
Matrix Service
MTRX
$326M
| $3.9M | ﹤0.01% |
518,536
+492,818
| +1,916% | +$4.64M |
|
3099
Treace Medical Concepts
TMCI
$280M
| $3.89M | ﹤0.01% |
208,824
+156,249
| +297% | +$3.22M |
|
3100
Caribou Biosciences
CRBU
$145M
| $3.89M | ﹤0.01% |
257,500
+182,826
| +245% | +$3.56M |
|
Similar funds
Millennium Management's Q4 2021 Portfolio in Review
As of Q4 2021, Millennium Management held 7,926 positions worth $197B, up 18% from $167B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Millennium Management deployed $20.8B of net new capital in Q4 2021, opening 1,213 new positions and adding to 2,561 existing holdings. Its largest new stake was Comcast: 3,028,627 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $291M trimmed.
- Millennium Management's largest Q4 2021 buy was Comcast: 3,028,627 shares worth $152M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $1.38B increase.
- Millennium Management's biggest Q4 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $291M.
- Millennium Management fully exited Kansas City Southern in Q4 2021, selling an estimated $227M.
- Millennium Management's ten largest holdings make up 19% of its $197B portfolio in Q4 2021.
- Millennium Management opened 1,213 new positions and closed 1,232 in Q4 2021.
- Millennium Management's portfolio value rose 18% quarter-over-quarter to $197B.
Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.